Skip to main content
. 2004 Mar;24(5):2063–2073. doi: 10.1128/MCB.24.5.2063-2073.2004

TABLE 1.

Nomenclature of targeted allelesa

Allele nomenclature Selectable marker Gene targeting strategy
Lmo1 Neomycin neo insertion
Lmo1Z Neomycin IRES-lacZ insertion
Lmo3 Neomycin neo insertion
Lmo3Z Neomycin IRES-lacZ insertion
Lmo4 Neomycin neo insertion
Lmo4-GFP Hygromycin GFP knockin
a

The various Lmo gene targeted alleles used in the study comprise either (i) gene inactivation by insertion of a gene encoding a selectable marker (either neomycin [neo] or hygromycin [hyg] genes) to create the Lmo allele, (ii) inactivation using insertion of an IRES-lacZ cassette including a neo gene to create the LmoZ allele, or (iii) knockin of the GFP gene in frame with the Lmo4 coding sequence (together with the hyg selectable marker) to create the Lmo4-GFP allele. Compound Lmo1 and Lmo3 genotypes comprising combinations of alleles are designated +/− (a wild-type and a neo insertion allele), Z/+ (IRES-lacZ insertion and a wild-type allele), and Z/Z (both alleles have IRES-lacZ insertions).